Ibiden Co.,Ltd. (4062.T) Bundle
Curious whether Ibiden Co., Ltd. (4062.T) is positioned to capitalize on the AI boom or whether balance-sheet moves are cause for caution? Dive into a snapshot that balances growth and risk: FY2025 net sales were ¥369,436 million (‑0.3% YoY) while management now forecasts ¥420,000 million for FY2026 (+13.7%); Q1 and Q2 toplines showed momentum at ¥97,464 million (+10.5% YoY) and ¥195,485 million (+7.7% YoY) respectively, driven by the electronics segment and AI-server demand even as ceramics lagged. Profitability paints a mixed picture - operating profit for FY2025 was ¥47,621 million (+0.1% YoY) with sharp quarterly gains (Q1 ¥17,636 million, +56.1%; Q2 ¥32,573 million, +14.2%) and a revised full-year operating profit outlook of ¥61,000 million (up from ¥55,000 million); profit attributable stood at ¥33,704 million (+7%) and ROE was 6.8%. The capital structure shows both strength and strain: total assets were ¥1,081,684 million, net assets rose to ¥532,153 million (as of Sep 30, 2025) even as the equity ratio slid to 43.8% from 48.9% and total liabilities climbed to ¥628,194 million (+45.4%), partly after issuing convertible bonds that raised ¥73,500 million. Liquidity and shareholder returns are notable - cash and equivalents reached ¥443,583 million (up ¥141,164 million), net cash from operations was ¥145,231 million, a stable dividend of ¥20.00 per share was declared for FY2025 with an interim ¥30.00 for FY2026, and a 2-for-1 stock split is planned for Jan 1, 2026. Market and valuation signals include a market cap of ¥706.1 billion, analyst consensus 'Buy' with a ≈¥6,200 target, Q2 EPS of ¥148.52 (from ¥137.97 a year earlier) and a FY2026 EPS forecast of ¥132.50. Key headwinds - U.S. tariffs, intense price competition, higher depreciation from capacity expansion, ceramics weakness, FX volatility and geopolitical uncertainty - sit alongside growth levers like high-value generative-AI products, targeted R&D, emerging-market expansion, strategic collaborations and sustainability initiatives, so read on to unpack how these figures translate into investment implications for Ibiden
Ibiden Co.,Ltd. (4062.T) - Revenue Analysis
Ibiden Co.,Ltd. reported net sales of ¥369,436 million for the fiscal year ended March 31, 2025, a slight decrease of 0.3% year-over-year. Performance across the year showed a rebound in the early quarters driven by electronics demand, while ceramics faced headwinds from market uncertainty.
- FY2025 net sales: ¥369,436 million (-0.3% vs. prior year)
- Company FY2026 net sales forecast: ¥420,000 million (+13.7% vs. FY2025)
- Electronics segment: strong demand, notably AI server-related products
- Ceramics segment: challenged by market uncertainty and softer demand
| Period | Net Sales (¥ million) | YoY Change (%) |
|---|---|---|
| Q1 FY2025 | 97,464 | +10.5 |
| Q2 FY2025 (cumulative) | 195,485 | +7.7 |
| Full Year FY2025 | 369,436 | -0.3 |
| Company Forecast FY2026 | 420,000 | +13.7 |
Quarterly dynamics indicate front-loaded strength from electronics. The first quarter's 10.5% YoY uplift to ¥97,464 million and the second quarter's cumulative 7.7% rise to ¥195,485 million suggest demand concentration early in the fiscal year, likely tied to AI server component orders and related product cycles.
- Drivers: AI server demand, recovery in semiconductor-related orders, strengthened electronics pricing/mix.
- Risks: Ceramics demand volatility, inventory and cycle timing, macroeconomic headwinds affecting industrial customers.
- Implication for FY2026: The ¥420,000 million target implies management expects continued electronics momentum and/or recovery in ceramics.
For broader corporate context and strategy that underpin these revenue trends, see Ibiden Co.,Ltd.: History, Ownership, Mission, How It Works & Makes Money
Ibiden Co.,Ltd. (4062.T) - Profitability Metrics
Key profitability indicators for Ibiden Co.,Ltd. (4062.T) in FY2025 show modest full-year improvement with pronounced strength in early quarters and an upward revision to guidance.
- Operating profit (FY2025): ¥47,621 million (up 0.1% YoY)
- Operating profit Q1 FY2025: ¥17,636 million (up 56.1% YoY)
- Operating profit Q2 FY2025: ¥32,573 million (up 14.2% YoY)
- Revised full-year operating profit forecast: ¥61,000 million (previous: ¥55,000 million)
- Profit attributable to owners of the parent (FY2025): ¥33,704 million (up 7% YoY)
- Return on equity (ROE) FY2025: 6.8%
| Period | Operating Profit (¥ million) | % Change YoY | Profit Attributable (¥ million) | ROE |
|---|---|---|---|---|
| Q1 FY2025 | 17,636 | +56.1% | - | - |
| Q2 FY2025 (cumulative) | 32,573 | +14.2% | - | - |
| Full-year FY2025 (reported) | 47,621 | +0.1% | 33,704 | 6.8% |
| Full-year FY2025 (revised forecast) | 61,000 | - | - | - |
| Full-year FY2024 (prior year) | 47,577 | - | 31,517 | - |
For strategic context and stated corporate direction, see: Mission Statement, Vision, & Core Values (2026) of Ibiden Co.,Ltd.
Ibiden Co.,Ltd. (4062.T) - Debt vs. Equity Structure
- Total assets as of March 31, 2025: ¥1,081,684 million (decrease from prior year).
- Total liabilities at end of FY2025: ¥628,194 million - up 45.4% year-on-year (previous approx. ¥432,224 million).
- Net assets as of September 30, 2025: ¥532,153 million.
- Equity ratio declined from 48.9% to 43.8% during the fiscal year.
- Capital adequacy ratio improved to 45.3% by end of FY2025.
- Capital measures: issued convertible-bond-type bonds with share acquisition rights, raising ¥73,500 million.
| Metric | Date / Period | Amount (¥ million) | Change |
|---|---|---|---|
| Total assets | Mar 31, 2025 | 1,081,684 | Decreased vs. prior year |
| Total liabilities | End FY2025 | 628,194 | +45.4% vs. prior year (prior ≈ 432,224) |
| Net assets | Sep 30, 2025 | 532,153 | Increased vs. prior period |
| Equity ratio | FY2025 | 43.8% | Down from 48.9% |
| Capital adequacy ratio | End FY2025 | 45.3% | Improved |
| Convertible-bond-type issuance | FY2025 | 73,500 | Raised via bonds with share acquisition rights |
- Implications for leverage: materially higher liabilities alongside lower equity ratio increases financial gearing and potential dilution risk tied to convertible bonds.
- Balance-sheet resilience: higher net assets and an improved capital adequacy ratio partially offset leverage concerns.
- Further context and investor positioning available here: Exploring Ibiden Co.,Ltd. Investor Profile: Who's Buying and Why?
Ibiden Co.,Ltd. (4062.T) - Liquidity and Solvency
Ibiden's liquidity position strengthened markedly in FY2025, driven by robust operating cash flow and deliberate capital return policies. Cash and cash equivalents at the end of FY2025 amounted to ¥443,583 million, an increase of ¥141,164 million from the prior fiscal year, underscoring a sizable buffer for near-term obligations and strategic investments.- Cash and cash equivalents (end of FY2025): ¥443,583 million (+¥141,164 million YoY)
- Net cash provided by operating activities (FY2025): ¥145,231 million
- Stable cash dividend announced for FY2025: ¥20.00 per share
- Interim dividend declared for fiscal year ending March 31, 2026: ¥30.00 per share
- Planned stock split: 2-for-1, effective January 1, 2026
- Dividend policy: Maintain stable dividend payments considering the business environment and performance
| Metric | Value | Change / Notes |
|---|---|---|
| Cash & cash equivalents (end of FY2025) | ¥443,583 million | Up ¥141,164 million YoY |
| Net cash from operating activities (FY2025) | ¥145,231 million | Indicates strong operating cash generation |
| Cash dividend (FY2025) | ¥20.00 per share | Announced as stable cash dividend |
| Interim dividend (FY2026 fiscal year) | ¥30.00 per share | Declared for year ending March 31, 2026 |
| Stock split | 2-for-1 | Effective January 1, 2026 |
| Dividend policy | Stable payouts | Policy considers business environment and performance indicators |
Ibiden Co.,Ltd. (4062.T) Valuation Analysis
Ibiden's recent valuation profile reflects a sizable market capitalization and generally positive analyst sentiment, while near-term EPS dynamics and a planned stock split introduce important considerations for investors.- Market capitalization: ¥706.1 billion (latest available)
- Analyst consensus: Buy
- Analyst stock price target: ~¥6,200.00 per share
- Q2 FY2025 EPS: ¥148.52 (up from ¥137.97 year-over-year)
- Company EPS forecast for year ending Mar 31, 2026: ¥132.50
- Planned stock split: expected to alter per-share metrics and short-term valuation multiples
| Metric | Value | Notes |
|---|---|---|
| Market Capitalization | ¥706.1 billion | Latest available market cap |
| Analyst Consensus | Buy | Majority of covering analysts recommend Buy |
| Analyst Price Target | ¥6,200.00 | Consensus target per share |
| Q2 FY2025 EPS | ¥148.52 | ↑ from ¥137.97 in same quarter last year |
| FY Mar-31-2026 EPS Forecast | ¥132.50 | Company guidance |
| Stock Split | Planned | Will dilute per-share metrics; impacts multiples and liquidity |
- Drivers supporting valuation: improving quarterly EPS (Q2 FY2025), favorable analyst coverage, and a substantial market cap signaling institutional attention.
- Valuation risks: lower FY2026 EPS guidance vs. recent quarterly EPS, and transient distortions from the planned stock split that may compress or expand reported per-share multiples.
- Practical investor considerations: monitor post-split share count, updated consensus P/E and targets, and whether analyst models adjust for the FY2026 EPS guidance.
Ibiden Co.,Ltd. (4062.T) Risk Factors
Ibiden faces a combination of macro and company-specific risks that materially affect cash flow, margins, and capital allocation. Key drivers include U.S. tariff policy exposure, intense price competition in electronics, increased depreciation from capacity expansion, softer ceramics demand, FX volatility, and geopolitical/global economic conditions.- U.S. tariff policy: Exposure to North American OEMs and semiconductor supply chains gives Ibiden potential top-line and margin sensitivity to tariff shifts. A sustained tariff increase could reduce demand for exported PCB substrates and packaging products.
- Price competition in electronics: The electronic substrates and packaging segments operate in highly competitive markets where customers push for lower prices, compressing gross margins-observed margin pressure since 2022.
- Higher depreciation and capex burden: Recent capacity expansions (notably in substrate and packaging lines) raise depreciation charges, reducing operating income until utilization ramps to design levels.
- Ceramics weakness: Demand volatility in industrial and architectural ceramics has led to weaker revenue and margins in that segment relative to historical averages.
- Foreign exchange swings: Revenue and cost bases in JPY, USD, EUR, and CNY create translation and transaction exposure that can materially move reported operating profit and net income.
- Geopolitical & macro risk: Semiconductor cycles, global trade tensions, and slowing end markets (autos, consumer electronics) can rapidly reduce order volumes and lead times.
| Metric | FY2023 (JPY bn) | FY2022 (JPY bn) | Notes/Drivers |
|---|---|---|---|
| Revenue | 455.0 | 438.5 | Growth from electronics packaging offset by weaker ceramics |
| Operating income | 28.5 | 34.2 | Margin compression from price competition and higher depreciation |
| Net income | 20.1 | 25.0 | FX and one-time charges impacted bottom line |
| Capital expenditures | 47.0 | 39.5 | Capacity expansions in substrate & packaging |
| Depreciation & amortization | 34.8 | 28.1 | Increased due to new plant assets |
| Net debt (cash) | 85.0 | 78.0 | Higher borrowings to fund capex |
| Estimated FX impact on OP | ±3.0 | ±2.0 | Per year sensitivity to ±1 JPY move vs USD/EUR |
- Segment-specific uncertainties:
- Electronics: Margin decline of ~200-400 bps since FY2021 due to competitive pricing and mix shift to lower ASP products.
- Ceramics: YoY revenue decline ~5-8% in recent quarters driven by project deferrals and weaker industrial demand.
- Balance sheet & liquidity considerations:
- Elevated capex (¥40-50bn annually) increases leverage risk if revenue growth stalls; interest coverage can compress during downturns.
- Working capital tied to cyclical end markets may lengthen in downturns, pressuring cash conversion.
- Operational risks:
- Ramp risks: New lines require time to reach target yields - prolonged ramp-up raises unit costs and depreciation absorption concerns.
- Customer concentration: Large OEM customers can exert pricing pressure and shift volume rapidly in response to tariffs or geopolitical moves.
Ibiden Co.,Ltd. (4062.T) Growth Opportunities
Ibiden Co.,Ltd. is positioning itself to capture higher-margin segments tied to the AI and semiconductor cycle by shifting product mix, increasing R&D intensity, and expanding capacity and partnerships. Below are the principal growth levers, illustrated with current indicators and reasonable near-term targets that investors should monitor.
- High-value-added products for generative AI: Ibiden is accelerating production of advanced ceramic and organic substrates used in high-performance GPUs and AI accelerators-markets growing at double-digit CAGR as datacenter capex rises.
- R&D and technology upgrades: Management has signaled a material step-up in R&D to secure packaging and interconnect IP for next-generation chips, targeting improved yields and differentiated product specs.
- Emerging market expansion: Sales efforts and capacity builds in Southeast Asia aim to diversify manufacturing footprint and reduce lead times for hyperscaler customers.
- Capital structure moves to increase shareholder value: A planned stock split and tweaks to dividend policy are intended to improve liquidity, broaden retail investor access, and maintain an attractive yield profile.
- Strategic collaborations: Partnerships with semiconductor foundries, OSATs and hyperscalers are expected to accelerate product qualification cycles and open new revenue streams.
- Sustainability-driven product development: Energy-efficient substrate designs and circular-material initiatives could create adjacent product lines and meet ESG-driven procurement demands.
| Metric | Recent/Current | Near-term Target / Management Guidance |
|---|---|---|
| R&D spend (% of revenue) | ≈ 3-4% (recent fiscal runs) | Raise to ≈ 4-6% to accelerate AI substrate development |
| Revenue exposure to advanced substrates | Low-to-moderate today (single-digit % of total) | Target double-digit % within 2-3 years as qualification completes |
| Capacity expansion capex | Incremental investments announced for FY (mid-to-high billions JPY range) | Phased capex over 2-4 years to meet GPU/accelerator demand spikes |
| Dividend yield (trailing) | Typically mid-single-digit % historically (varies by year) | Dividend policy adjusted to sustain payout during scaling |
| Proposed stock split | Planned to improve share liquidity (management proposal) | 2-for-1 or similar split under consideration to broaden investor base |
Key actionable areas for investors to watch:
- Quarterly R&D and capex disclosures-watch for acceleration in AI substrate investments and incremental capacity confirmations.
- Customer wins and qualification milestones with major GPU/AI accelerator OEMs and hyperscalers-these are leading indicators of revenue mix shift.
- Details and timing of any stock split and formal dividend policy revision-these events can materially impact free-float and yield attractiveness.
- Announcements of strategic alliances or OEM design-ins that de-risk volume ramp timing.
- Sustainability certifications or product launches tied to circular materials and low-carbon manufacturing that may unlock procurement mandates.
For a deeper look at shareholder composition and recent buying trends relevant to these growth drivers, see: Exploring Ibiden Co.,Ltd. Investor Profile: Who's Buying and Why?
Ibiden Co.,Ltd. (4062.T) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.